SAS Output

16-OCT-2019 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 148 43 16 10 6 3 2 07/25/2016 177 80
        2 Cabozantinib   42 15 10 5 2 0      
        3 Crizotinib   28 0 0 0 0 0      
        4 Savolitinib   30 1 0 0 0 0      
            143 32 20 11 5 2      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 T 1 TICE BCG 969 168 110 67 21 0 0 02/24/2017 189 89
        2 Tokyo-172 BCG   168 111 69 23 0 0      
        3 Prime + Tokyo-172 BCG   167 113 68 21 0 0      
            503 334 204 65 0 0      
 
  S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 119 112 67 44 16 4 09/24/2018 268 116
            119 112 67 44 16 4      
 
    2 Y 1 Standard Systemic Therapy Only 1273 32 31 21 13 5 1 09/24/2018    
        2 SST + Surgery/RT   33 32 23 14 3 1      
            65 63 44 27 8 2      
 
  S1806-Blad, MIBC, ChemoRT +/- Atezolizumab 1 Y 0 Initial Registration 475 14 14 14 11 4 0 06/03/2019 210 98
            14 14 14 11 4 0      
 
    2 Y 1 Chemo + RT 475 6 6 6 4 1 0 06/03/2019    
        2 Chemo + RT + Atezolizumab   5 5 5 4 1 0      
            11 11 11 8 2 0      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   6 2 1 0 0 0 11/23/2016 61 37
            6 2 1 0 0 0      
 
  A031702-GU, Mets, Cabozantinib+Nivo+Ipi (ICONIC) 1 E Total Registrations   4 4 4 4 1 0 08/09/2019 74 23
            4 4 4 4 1 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   73 51 28 20 6 0 09/29/2017 253 127
            73 51 28 20 6 0      
 
    1 E Total Registrations   64 47 27 19 7 0 09/29/2017    
            64 47 27 19 7 0      
 
  EA8171-PROS, newly diagnosed, mpMRI for pre-op stagi 1 E Total Registrations   14 14 11 7 2 1 02/11/2019 81 34
            14 14 11 7 2 1      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   3 2 0 0 0 0 08/24/2017 191 93
            3 2 0 0 0 0      
 
    2 E Total Registrations   3 2 0 0 0 0 08/24/2017    
            3 2 0 0 0 0      
 
  NRGGU005-PROS, intmd risk, IGRT& SBRT vs IGRT& HF-IMRT 1 E Total Registrations   1 1 0 0 0 0 03/19/2019 242 108
            1 1 0 0 0 0      
 
  NRGGU006-PROS, post-RP PSA, SRT +/- ADT w/Apalutamide 1 E Total Registrations   2 2 0 0 0 0 03/22/2019 79 31
            2 2 0 0 0 0      
 
    2 E Total Registrations   2 2 2 0 0 0 03/22/2019    
            2 2 2 0 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   54 45 19 9 1 1 05/03/2018 225 131
            54 45 19 9 1 1      
 
    1 E Total Registrations   52 43 20 14 2 0 05/03/2018    
            52 43 20 14 2 0      
 
  A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   1 1 0 0 0 0 12/17/2018 100 43
            1 1 0 0 0 0      
 
    2 E Total Registrations   1 1 0 0 0 0 12/17/2018    
            1 1 0 0 0 0      
 
  A031704-RCC, Met, Ipi+Nivo followed by Nivo+/-Cabo 1 E Total Registrations   1 1 1 1 1 0 10/02/2019 6 2
            1 1 1 1 1 0      
 
  EA8134-Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E Total Registrations   4 4 4 3 0 0 04/25/2019    
            4 4 4 3 0 0      
 
  EA8153-Pros, ADT + Abira +/- Cabazitaxel (CHAARTED2) 1 E Total Registrations   17 15 12 10 4 1 08/08/2018 235 95
            17 15 12 10 4 1